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Abstract
Background Although capsule formation is a natural-
healing process following breast augmentation using
implants, a contracted capsule around a poorly positioned
implant can act as an obstacle during the corrective pro-
cedure to reposition the implant. The ideal treatment of
capsular contracture is removal of the capsule and covering
the implant with a healthy envelope without scar tissue.
However, total capsulectomy in the submuscular space
may be difﬁcult, especially if the capsule is ﬁrmly attached
to the chest wall. This situation may require a highly
skilled technique because aggressive capsulectomy could
injure the intercostal muscles and vasculature and cause
further complications such as pneumothorax. Therefore,
the authors have developed a new, less traumatic method of
leaving the capsule behind the new implant.
Method From February 2001 through February 2009, the
authors treated 74 patients (139 breasts) using a subpec-
toral, precapsular implant repositioning technique. These
patients suffered from capsular contracture or implant
malposition after submuscular breast augmentation. The
technique is composed of three parts. First, a plane was
developed between the anterior wall of the capsule and the
posterior surface of the pectoralis major muscle using a
periareolar or inframammary approach. After removing the
previous implant, the anterior wall of the capsule was fully
released from the posterior surface of the pectoralis major
muscle and ﬁxed to the posterior wall of the capsule which
adhered to the chest wall. The new implant was inserted
into the developed subpectoral space, anterior to the
capsule.
Results The mean age of the patients was 31 years
(range = 24–52) and the time between the primary and the
secondaryaugmentationwas42 months(range = 4 months
to12 years).Therangeforfollow-upwasfrom12 monthsto
5 years. Median follow-up was 26 months. Postoperative
complications included two cases of hematoma but no cases
of infection, muscle distortion, or double-bubble deformity.
Conclusion This technique is a valid alternative treatment
for capsular contracture or malpositioned implant after
breast augmentation surgery. It may be less traumatic than
the conventional method of total capsulectomy. In addition,
thistechniquereducestherelapserateofcapsularcontracture
signiﬁcantly compared to a partial capsulectomy or capsu-
lotomy as the new implant is inserted into a scar tissue-free
environment. Good aesthetic results and patient satisfaction
wasachievedusingthismethod.Inourexperience,thisnovel
technique is a good alternative method of correcting com-
plications of submuscular implant augmentation.
Keywords Secondary breast augmentation  Capsular
contracture  Implant malposition
Breast augmentation is one of the most popular cosmetic
surgery procedure. Most of these cases have a high rate of
patient satisfaction. However, some women undergo revi-
sion to their implants for various reasons. One of eight
women with breast implants will have more than one sur-
gery on her breasts [1]. Major reasons for further operations
include capsular contracture and improvement of implant
position and breast shape.
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DOI 10.1007/s00266-011-9714-zCapsule formation around an implant is a result of an
immune reaction to the foreign body; the natural response
of any living tissue to a foreign object, even inert material.
Since the early days of breast augmentation, severe capsular
contracture has remained a leading reason for a secondary
operation. This complication compromises aesthetic results
and causes pain and discomfort to the patient, requiring
further treatment or implant removal. The Baker system has
remained the gold standard for the classiﬁcation of capsular
contractures. In general, grades I and II are acceptable,
whereas grades III and IV usually require surgical inter-
vention. The ideal treatment for capsular contracture is the
removal of the capsule along with covering the implant with
a healthy envelope without scar tissue. The most effective
treatment for capsular contracture grades III and IV is
usually implant removal followed by total capsulectomy
and reimplantation. However, a total capsulectomy in the
submuscular space could be difﬁcult, especially if the
capsule is tightly ﬁxed to the chest wall. It may also lead to
damage of the surrounding tissue [2]. Aggressive attempts
to completely excise in these cases may lead to injury of the
intercostal muscle, cause a pneumothorax, or produce major
bleeding from intercostal vasculature, which in turn may
cause another capsular contracture. Therefore, we have
developed a less traumatic and more useful method that
leaves the capsule behind the new implant instead of car-
rying out a total capsulectomy. Another option is to use the
prepectoral (subglandular) space for the insertion of the new
implant. However, in patients with a relatively small
amount of breast tissue or thin skin, this method may
achieve suboptimal cosmetic results (the breast shape may
be unnatural or the implant may be visible under the skin).
In these patients, use of the submuscular plane is a more
desirable option. Our technique is also useful in cases of
implant malposition. Traditionally, external compression
using taping or garments, bolster ﬁxation, percutaneous
suture, and internal capsulorrhaphy have been used to treat
implant malposition. However, these methods were often
insufﬁcient and showed a high recurrence rate [3].
This report describes a novel method for treating cap-
sular contracture and implant malposition. This technique
is based on studies that showed that the retained capsules
could be resorbed by the body or transformed into ﬁbrous
tissue following removal of the implant if there was no
inﬂammation or calciﬁcation [4]. It is expected that this
technique may be effectively utilized for a secondary
operation after submuscular breast augmentation.
Materials and Methods
Over an 8-year period between February 2001 and February
2009, 74 patients (139 breasts) with capsular contracture or
implant malposition post submuscular breast augmentation
were treated using the surgical technique described below.
Fifty-one patients had capsular contractures and 23 patients
had implant malposition. Sixty-ﬁve cases were bilateral
and nine cases were unilateral. Of the cases of capsular
contracture, grade III accounted for 32 and the remaining
19 were grade IV. The 23 cases of implant malposition
included 5 cases of bottoming out, 1 case of double-bubble
deformity, 15 cases of upward migration, and 2 cases of
symmastia. Of the 74 patients, 47 had had primary breast
augmentation using silicone implants and 27 had saline
implants. Four types of implants were used in the correc-
tive operation over the 8-year period: saline smooth
implants were used in 28 patients, saline textured implants
in 4, cohesive gel-type silicone smooth implants in 18,
and cohesive gel-type silicone textured implants in 24
patients.
Surgical Technique
Before the operation, preoperative marking was done with
the patient standing with arms at rest, facing forward. The
midline, current inframammary fold line, planned infra-
mammary fold line, the boundary of the pocket to be dis-
sected, and the incision line were marked. In the cases of
capsular contracture, the dissection boundary followed the
implant size and proﬁle, degree of glandular ptosis, tissue
elasticity of breast parenchyma, and skin. In the cases of
implant malposition, the dissection pocket was more
meticulously designed to meet an adequate new implant
position.
With the patient under general anesthesia and arms
abducted to 90, the marked incision line was inﬁltrated
with a local anesthetic solution (1% lidocaine mixed with
epinephrine 1:200,000). Tumescent solution was carefully
injected into the target region in the subglandular plane so
that the implant was not punctured. Afterwards, the inci-
sion was made on the planned inframammary fold line.
The boundary of dissection followed the preoperative
design. In cases of capsular contracture, adequate dissec-
tion can be measured according to implant size, proﬁle, and
ptosis of glandular tissue. In cases of upward implant
malposition, adequate lowering of the inframammary fold
line in the subpectoral and subglandular planes is required.
In cases of bottoming out and double-bubble deformity
cases, the amount of the dissection needs to correspond to
an appropriate line of the new inframammary fold.
After the incision was made, subcutaneous tissue was
dissected down to the deep fascia; the subglandular plane
was also dissected. The upper limit of the subglandular
dissection area was set using the degree of glandular ptosis
according to the dual-plane augmentation principle by
Tebbetts [5]. The free margin of the pectoralis major
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123muscle was dissected from the capsule. At this time, a
subpectoral dissection was performed between the poster-
ior surface of the pectoralis major muscle and the anterior
surface of the anterior wall of the capsule. Thus, the new
virgin plane—subpectoral and anterior to the anterior wall
of the capsule—could be created for a new implant
(Fig. 1).
After conﬁrming that the entire anterior surface of the
capsule can be seen, a central incision was made in the
anterior surface of the capsule to remove the existing
implant. The internal surface of the capsule was well irri-
gated using normal saline and a betadine solution. The
anterior and posterior walls of the capsule were tightly
sutured with three or nine stitches to avoid separation. This
procedure is critical to avoid seroma formation and
downward migration of the new implant in the upright
position postoperatively. However, in cases of upward
implant malposition, the tight suturing between the anterior
wall and the posterior wall of the capsule is not necessary.
The peripheral edge of the capsule, especially the inferior
half, was sometimes thick, probably due to the accumula-
tion of ﬂuid and hematoma after the initial operation. The
thick, band-like scar tissue at the periphery should be
carefully and meticulously dissected and removed. If any
Fig. 1 Diagram of new
subpectoral, anterocapsular
implant repositioning technique.
Top left Preoperative lateral
view. Top right Dissection
between pectoralis major
muscle and anterior surface of
capsule via inframammary
incision. Bottom left Implant
removal and tucking of anterior
capsule to the posterior capsule
and chest wall. Bottom right
New implant insertion above
previous capsule in dual-plane
pocket
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123scar tissue remains on the subglandular and subpectoral
planes, it could prohibit covering of the implant with a scar
tissue-free envelope, which can result in double bubble-
deformity or a constriction band at that point.
To prevent a seroma or reactive ﬂuid collection caused
by remaining free spaces of the capsule, a small incision at
the dependent portion of the anterior capsule was made for
drainage. After achieving hemostasis using electrocauteri-
zation, the developed plane for the new implant was irri-
gated using normal saline and betadine solution and the
new implant was inserted. A negative suction drain was
inserted and the incision was closed. The wound was
dressed with compression bandaging around the thorax.
The drain was removed 1 or 2 days after the operation and
the patient was discharged with a specially made tight
support bra (Make Up Bra
, VM21 Co., Seoul, Korea)
(Fig. 2, bottom photo). If the shell of the new breast
implant was smooth, the displacement exercise was applied
one week after the operation four times a day for 2 or
3 months. However, if the shell of the new breast implant
was textured, no displacement exercise was recommended.
Results
The average age of the patients was 31 years (ran-
ge = 24–52 years) and the average volume of the implants
used was 270 cm
3 (range = 175–350 cm
3). The amount of
time between the primary mammaplasty and the corrective
operation varied, ranging from 4 months to 12 years
(mean = 42 months). The follow-up period ranged from
12 months to 5 years (mean = 26 months). Two cases of
hematoma were observed, but there were no other com-
plications such as seroma formation or infections. The
capsular contracture Baker class III recurred in three cases
(Figs. 2, 3, 4). The 54 patients who underwent the opera-
tion from October 2002 were prescribed leukotriene
antagonists for 3 months following surgery [6].
Discussion
Implant-based augmentation mammaplasty has developed
continuously since its introduction in the 1960s, in both the
technique and the implants used. The resulting shape, feel,
and consistency of the implant are key to a successful
operation. Therefore, preventing capsular contracture is of
the utmost importance. Although there are many ways to
reduce the risk of capsular contractures, it is not always
possible to prevent them as capsular contracture is induced
by various patient and local breast factors [7, 8] that are not
easily controlled. Prevention is the best way of treating
capsular contractures, but the rate of their development has
not decreased despite continual efforts to achieve this. In
addition, a capsule that results from the natural-healing
process complicates the correction of implant malposition.
Thus, it is very important to learn how to deal with a
formed capsule in a secondary operation.
Closedcapsulotomyhasbeen usedextensivelyinthe past
forthetreatmentofestablishedcapsularcontractureandwas
especiallypopularfromthelate1970sthroughthe1980s[9].
Today, however, closed capsulotomy is rarely performed
because of its frequent association with complications such
as extracapsular rupture, implant displacement, hematoma
formation, and uneven capsule release [10]. In addition, a
highrecurrencerateofthecapsularcontracturehasalsobeen
reported [11]. As a consequence, closed capsulotomy no
longer has a role in the management of capsular contracture,
and the FDA has declared this procedure contraindicated.
Open capsulotomy, or scoring of the capsule without
removing it, is similarly unsuccessful and has a contracture
recurrence rate of over 50% [11]. It is also difﬁcult to make
an accurately expected pocket with an open capsulotomy
procedure. Situations where an open capsulotomy is a rea-
sonable treatment of choice include correction of a malpo-
sitioned implant when the breast is soft but the implant is
misplacedduetoatechnicalerrorinformationofthepocket.
However, it can bring about unwanted results because of
unequal capsule tension. Therefore, due to their complica-
tions and high recurrence rates, open and closed capsuloto-
mies are not recommended as effective treatments.
The most effective treatment for capsular contracture,
therefore, is total capsulectomy and the insertion of a new
implant, but this is a difﬁcult procedure, especially in cases
of submuscular augmentation. A thick capsule adherent to
the chest wall can be very difﬁcult to excise. Aggressive
attempts to totally excise such a capsule may injure inter-
costal muscle, cause a pneumothorax, or produce major
blood loss. Partial capsulectomy, which is excision of the
anterior segment of the capsule, is easier and safer than total
capsulectomy, but the recurrence rate is higher [2]. The
recurrence rates following capsulotomy and partial capsul-
ectomy are higher than that of total capsulectomy because
therearenoenvironmentalchangessurroundingtheimplant,
and the remaining capsule may act as a nidus for the
development of another capsular contracture. If the anterior
capsule is excised and the posterior surface of the capsule
remains, the newly inserted implant will be in contact with
the posterior wall of the capsule which isproblematic tissue,
i.e., bioﬁlm [12] by subclinical bacterial inoculation, and,
thus, capsular contracture is more likely to occur.
The technique presented in this report makes it possible
to easily dissect and create conditions similar to total
capsulectomy in a novel, scar tissue-free environment.
Without disturbing the posterior aspect of the capsule
adjoining the chest wall, the anterior surface of the capsule
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new space was created behind the muscle and anterior to
the capsule; a new pocket was created so that an implant
may be placed there. In cases of infected capsule, calciﬁed
capsule, or ruptured capsule where silicone gel was
released, it is undesirable to retain the capsule. In these
circumstances, a total capsulectomy is preferable [4, 13].
As described, postoperative recurrence of capsular
contractures can be reduced with this technique because the
implant does not come in contact with the inner surface of
Fig. 2 A 33-year-old woman.
Left column Two years after
breast augmentation. The
patient suffered from capsular
contracture. Right column Ten
months after revision
augmentation mammaplasty
with subpectoral, precapsular
implant repositioning technique.
Bottom Postoperative garment
(Makeup bra
). Note that we
can form the inframammary
crease easily and rapidly and
can achieve lower-pole
expansion effectively because
the upper band compresses the
breast mound and the lower
band restrains the
inframammary crease
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123the capsule. Moreover, the shape and size of the new
pocket can be formed as desired by the patient, similar to
the initial operation. However, there is some controversy
regarding how the retained capsule may change over time.
Hardt et al. [14] reported that retained implant capsules
may evolve to take several forms, including a speculated
mass similar to a breast carcinoma, dense calciﬁcations that
obscure the neighboring breast tissue on imaging studies,
or a cystic mass due to persistent serous effusion, expansile
hematoma, or encapsulated silicone-ﬁlled cysts. However,
Fig. 3 A 33 year-old woman.
Left column 3 years later after
transaxillary subpectoral breast
augmentation. Note the upward
migration of the bilateral breast
due to capsular contracture.
Right column postoperative
6 month view
Fig. 4 Left A 33-year-old
woman with symmastia after
original breast augmentation.
Right Postoperative 9-month
view
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123Rockwell et al. [4] described retained capsules that were
still present after silicone gel implant removal. Cihat et al.
[15] reported that retained capsules would most likely
disappear in time if the capsule is not stimulated by the
implant. We also believe that retained capsules will be
resorbed or thinned over time. Consequently, we need
more long-term follow-up studies with radiological and
histological surveys [16].
Leukotriene antagonists are known to effectively pre-
vent capsular contractures [17]. Zaﬁrlukast (Accolate
,
AstraZeneca, Wilmington, DE) was prescribed to all
patients postoperatively since October 2002, except for
patients with hepatic dysfunction (due to its association
with hepatic failure). No signs of hepatotoxic effects were
observed following the leukotriene antagonist therapy.
Conclusion
The described technique in this report makes possible a
secondary operation that reduces capsular contracture
through a scar tissue-free environment, unlike a partial
capsulectomy or capsulotomy. Furthermore, the dissection
of the capsule is made signiﬁcantly easier than in cases of
total capsulectomy. We feel that further prospective studies
on a larger scale are necessary to examine this technique
further and hope that this report will contribute to the
treatment of this feared complication of a common
procedure.
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